• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PureTech Health plc - American Depositary Shares (NQ:PRTC)

17.42 UNCHANGED
Last Price Updated: 4:00 PM EDT, May 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about PureTech Health plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
PureTech Founded Entity Akili Announces PLOS ONE Publication of Clinical Study Results and EEG Data Showing Akili Digital Therapeutic EndeavorRx® Activates Systems in Brain Key to Attentional Functioning
February 17, 2022
From PureTech Health plc
Via Business Wire
News headline image
PureTech Founded Entity Akili Interactive Announces Filing of Registration Statement on S-4 in Connection with its Proposed Business Combination with Social Capital Suvretta Holdings Corp. I
February 15, 2022
From PureTech Health
Via Business Wire
News headline image
PureTech to Present at the SVB Leerink 11th Annual Global Healthcare Conference
February 10, 2022
From PureTech Health
Via Business Wire
News headline image
PureTech Founded Entity Gelesis to Launch Plenity® National Media Campaign That Challenges Restrictive Dieting Norms
January 31, 2022
From PureTech Health plc
Via Business Wire
News headline image
PureTech Founded Entity Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. I
January 26, 2022
From PureTech Health plc
Via Business Wire
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
January 21, 2022
Gainers Biophytis (NASDAQ:BPTS) shares rose 12.3% to $5.28 during Friday's regular session. The market value of their outstanding shares is at $68.0 million. Intra-... 
Via Benzinga
News headline image
Gelesis, Maker Of Weight Loss Pill, Concludes SPAC Deal; Trading Kickstarts Today ↗
January 14, 2022
PureTech Health plc (NASDAQ: PRTC) founded entity Gelesis Inc, maker of weight management aid, has completed its business combination with Capstar Special... 
Via Benzinga
News headline image
PureTech Founded Entity Gelesis, the Maker of Plenity® for Weight Management, Will Debut as a Publicly Traded Company Following the Closing of its Business Combination with Capstar
January 14, 2022
From PureTech Health plc
Via Business Wire
News headline image
PureTech to Present at 40th Annual J.P. Morgan Healthcare Conference
January 07, 2022
From PureTech Health plc
Via Business Wire
News headline image
PureTech’s LYT-100 (Deupirfenidone) Achieves 50% Reduction in Healthy Older Adults Experiencing GI-Related Adverse Events Compared to Pirfenidone
January 06, 2022
From PureTech Health plc
Via Business Wire
News headline image
PureTech Founded Entity Gelesis Appoints Inogen Co-Founder and Former CFO Ali Bauerlein to Board of Directors and Audit Committee
January 05, 2022
From PureTech Health plc
Via Business Wire
News headline image
PureTech Provides End of Year Report on Key Progress Across Wholly Owned Programs and Founded Entities
December 16, 2021
From PureTech Health
Via Business Wire
News headline image
PureTech Presents Preclinical Proof-of-Concept Data for LYT-300 (Oral Allopregnanolone) as Potential Treatment for Neurological and Neuropsychological Conditions
December 08, 2021
From PureTech Health plc
Via Business Wire
News headline image
PureTech Advances Wholly-Owned Candidate LYT-300 (Oral Allopregnanolone) into Clinical Study for Potential Treatment of Neurological and Neuropsychological Conditions
December 07, 2021
From PureTech Health plc
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
December 02, 2021
Gainers Biofrontera (NASDAQ:BFRI) shares ... 
Via Benzinga
News headline image
PureTech Founded Entity Gelesis Announces FDA-Cleared Weight Management Approach, Plenity®, Now Broadly Available and Leading Nutrition Authority Joy Bauer, MS, RDN, CDN, Joins as Chief Nutrition Officer
December 01, 2021
From PureTech Health plc
Via Business Wire
News headline image
PureTech Founded Entity Gelesis Receives $30 Million Plenity® Order from Ro
November 18, 2021
From PureTech Health plc
Via Business Wire
News headline image
PureTech Announces Publication of Phase 1 Results for LYT-100 in the Journal Clinical Pharmacology in Drug Development and Provides Timing Updates
November 16, 2021
From PureTech Health plc
Via Business Wire
News headline image
PureTech Announces Participation in Two Upcoming Investor Conferences
November 15, 2021
From PureTech Health plc
Via Business Wire
News headline image
PureTech Presents Clinical Trial Design Supporting Wholly Owned Immuno-Oncology Candidate LYT-200 at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
November 12, 2021
From PureTech Health plc
Via Business Wire
News headline image
PureTech Receives Orphan Drug Designation for Wholly Owned Candidate LYT-200 for the Treatment of Pancreatic Cancer
November 11, 2021
From PureTech Health plc
Via Business Wire
News headline image
PureTech Founded Entity Karuna Therapeutics and Zai Lab Announce Strategic Collaboration for Development, Manufacturing, and Commercialization of KarXT in Greater China
November 09, 2021
From PureTech Health plc
Via Business Wire
News headline image
PureTech Announces Participation at the Jefferies London Healthcare Conference
November 09, 2021
From PureTech Health plc
Via Business Wire
News headline image
PureTech Is Pleased to Note Publication in Nature’s Scientific Reports Featuring the Gelesis Foundational Biomimetic Platform for Treating Obesity and Conditions Related to Diet-Induced Gut Damage
November 01, 2021
From PureTech Health plc
Via Business Wire
News headline image
PureTech Founded Entity Vedanta Biosciences Appoints Simona Levi as Chief Legal Officer and Corporate Secretary
October 14, 2021
From PureTech Health plc
Via Business Wire
News headline image
PureTech Founded Entity Vedanta Announces Positive Topline Phase 2 Data for VE303 in High-Risk C. difficile Infection and Exercise of $23.8 Million Option by BARDA
October 05, 2021
From PureTech Health plc
Via Business Wire
News headline image
PureTech Founded Entity Sonde Health Launches Vocal Biomarker Technology to Monitor Mental Health and Well-Being
October 05, 2021
From PureTech Health plc
Via Business Wire
News headline image
PureTech Founded Entity Akili Announces Topline Results from Shionogi Phase 2 Study in Japan
September 29, 2021
From PureTech Health plc
Via Business Wire
News headline image
PureTech Announces Publication of New Preclinical Research from Collaborators that Supports Mesenteric Lymphatic Dysfunction as a Potential Cause of and Therapeutic Target for Obesity and Insulin Resistance
September 20, 2021
From PureTech Health plc
Via Business Wire
News headline image
PureTech to Present at Oppenheimer Fall Healthcare Life Sciences and MedTech Summit
September 14, 2021
From PureTech Health plc
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap